Cross-cultural Adaptation and Linguistic Validation of the Korean Version of the Leeds Assessment of Neuropathic Symptoms and Signs Pain Scale.
10.3346/jkms.2015.30.9.1334
- Author:
Cholhee PARK
1
;
Youn Woo LEE
;
Duck Mi YOON
;
Do Wan KIM
;
Da Jeong NAM
;
Do Hyeong KIM
Author Information
1. Department of Anesthesiology and Pain Medicine, Gangnam Severance Hospital, Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul, Korea.
- Publication Type:Original Article ; Observational Study ; Validation Studies
- Keywords:
Neuralgia;
Symptom Assessment;
Validation Studies
- MeSH:
*Cross-Cultural Comparison;
Diagnosis, Differential;
*Diagnostic Techniques, Neurological;
England;
Female;
Humans;
Male;
Middle Aged;
Neuralgia/classification/*diagnosis;
Nociceptive Pain/*diagnosis;
Observer Variation;
Pain Measurement/*methods;
Reproducibility of Results;
Republic of Korea;
Sensitivity and Specificity;
Surveys and Questionnaires;
Symptom Assessment/methods;
*Translating
- From:Journal of Korean Medical Science
2015;30(9):1334-1339
- CountryRepublic of Korea
- Language:English
-
Abstract:
Distinction between neuropathic pain and nociceptive pain helps facilitate appropriate management of pain; however, diagnosis of neuropathic pain remains a challenge. The aim of this study was to develop a Korean version of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale and assess its reliability and validity. The translation and cross-cultural adaptation of the original LANSS pain scale into Korean was established according to the published guidelines. The Korean version of the LANSS pain scale was applied to a total of 213 patients who were expertly diagnosed with neuropathic (n = 113) or nociceptive pain (n = 100). The Korean version of the scale had good reliability (Cronbach's alpha coefficient = 0.815, Guttman split-half coefficient = 0.800). The area under the receiver operating characteristic curve was 0.928 with a 95% confidence interval of 0.885-0.959 (P < 0.001), suggesting good discriminate value. With a cut-off score > or = 12, sensitivity was 72.6%, specificity was 98.0%, and the positive and negative predictive values were 98% and 76%, respectively. The Korean version of the LANSS pain scale is a useful, reliable, and valid instrument for screening neuropathic pain from nociceptive pain.
